SGLT2 inhibitors reduce cardiovascular death or hospitalization for heart failure, regardless of the presence or absence of diabetes in patients at high cardiovascular risk and in those with heart failure and reduced ejection fraction (HFrEF). In patients with HF and preserved EF, empagliflozin also showed favorable effects mainly related to the reduction of hospitalization for heart failure. These favorable effects are beyond the reduction of glycemic levels and mainly related to beneficial hemodynamic and anti-inflammatory effects of these drugs and improved cardiac energy metabolism. In this review, we aimed to evaluate the effects of SGLT2 inhibitor on cardiac remodeling and function, which is still incompletely clear.
Novo, G., Guarino, T., Di Lisi, D., Biagioli, P., Carluccio, E. (2022). Effects of SGLT2 inhibitors on cardiac structure and function. HEART FAILURE REVIEWS [10.1007/s10741-022-10256-4].
Effects of SGLT2 inhibitors on cardiac structure and function
Novo, Giuseppina;Guarino, Tommaso;Di Lisi, Daniela;
2022-06-16
Abstract
SGLT2 inhibitors reduce cardiovascular death or hospitalization for heart failure, regardless of the presence or absence of diabetes in patients at high cardiovascular risk and in those with heart failure and reduced ejection fraction (HFrEF). In patients with HF and preserved EF, empagliflozin also showed favorable effects mainly related to the reduction of hospitalization for heart failure. These favorable effects are beyond the reduction of glycemic levels and mainly related to beneficial hemodynamic and anti-inflammatory effects of these drugs and improved cardiac energy metabolism. In this review, we aimed to evaluate the effects of SGLT2 inhibitor on cardiac remodeling and function, which is still incompletely clear.File | Dimensione | Formato | |
---|---|---|---|
SGLT2.pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
795.38 kB
Formato
Adobe PDF
|
795.38 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.